This “Natural” Injection Promises Pain Relief, Hair Growth, and More. But Does It Work And Is It Safe?

Doctors share everything to know about the buzzy treatment.
Good Morning America

Eli Lilly launches new weight-loss drug Zepbound KwikPen: What to know

The FDA-approved Zepbound KwikPen delivers a full month of treatment in one device and will be available to self-pay patients through LillyDirect starting Feb. 23.

What exactly are GLP-1 medications and how do they work?

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Lilly to launch multi-dose weight-loss drug device in US

Feb 23 (Reuters) - Eli Lilly said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, delivering a full month of the ...